Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

Stents

Products

 

 

e-ULTIMASTER Trialhttps://www.terumo-europe.com/en-emea/clinicaldata/e-ultimaster-triale-ULTIMASTER Trial<p>​One of the largest, prospective worldwide registries<br></p>HayabusaArticlePage
Ultimaster Clinical Programhttps://www.terumo-europe.com/en-emea/clinicaldata/the-comprehensive-clinical-programmeUltimaster Clinical ProgramHayabusaArticlePage
CENTURY II Trialhttps://www.terumo-europe.com/en-emea/clinicaldata/century-iiCENTURY II Trial<ul><li>Multicentre, intercontinental study: 58 sites in 13 countries across Europe, Japan, and South Korea </li><li>Primary endpoint: freedom from TLF at 9 months</li><li>Secondary endpoint: rate of TVF; patient-oriented composite endpoint; rate of TLR, TVR, ST, cardiac death, MI; composite of cardiac death and MI; rate of bleeding and vascular complications </li><li>Clinical follow-up up to 5 years </li><li>Stage: Published and completed<br></li></ul>HayabusaArticlePage

 

 

 

 

 

 

Terumo to Launch the Ultimaster Tansei Drug Eluting Stent in Europehttps://www.terumo-europe.com/en-emea/news/terumo-to-launch-the-ultimaster-tansei-drug-eluting-stent-in-europeTerumo to Launch the Ultimaster Tansei Drug Eluting Stent in EuropeTokyo, Japan23/05/2018 22:00:00
Terumo receives CE Mark for Ultimaster TANSEI drug-eluting stenthttps://www.terumo-europe.com/en-emea/news/terumo-receives-ce-mark-for-ultimaster-tansei-drug-eluting-stentTerumo receives CE Mark for Ultimaster TANSEI drug-eluting stentLeuven, Belgium22/04/2018 22:00:00
First patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientshttps://www.terumo-europe.com/en-emea/news/first-patient-enrolled-in-major-new-study-investigating-abbreviated-dapt-post-stent-in-high-bleeding-risk-patientsFirst patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientsEmmen, The Netherlands03/04/2017 22:00:00

 

 

ESC 2019https://www.terumo-europe.com/en-emea/Events/ESC 2019.aspxESC 2019France30/08/2019 22:00:0004/09/2019 16:00:00Parishttps://www.escardio.org/Congresses-%26-Events/World-cardio-agenda/esc-congress-2019, https://www.escardio.org/Congresses-%26-Events/World-cardio-agenda/esc-congress-2019
Euro CTO Club 2019https://www.terumo-europe.com/en-emea/Events/Euro CTO Club 2019.aspxEuro CTO Club 201912/09/2019 22:00:0014/09/2019 16:00:00https://eurocto2019.eu/, https://eurocto2019.eu/